NCT03509883View on ClinicalTrials.gov

Bioavailability of Apixaban Sprinkle Compared to Apixaban Capsules

PHASE1CompletedINTERVENTIONAL
Enrollment

94

Participants

Timeline

Start Date

April 26, 2018

Primary Completion Date

June 15, 2018

Study Completion Date

June 15, 2018

Conditions
Healthy Volunteers
Interventions
DRUG

Drug: Apixaban sprinkle capsules

Single dose (25 x 0.1 mg capsules), oral administration

DRUG

Experimental: Apixaban tablets followed by apixaban sprinkle capsules

Apixaban sprinkle capsules Single dose (25 x 0.1 mg capsules), oral administration

Trial Locations (1)

78744

PPD Development, LP, Austin

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY